These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29687693)
21. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice? Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678 [TBL] [Abstract][Full Text] [Related]
22. National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis. Gilani S; Pynnonen MA; Shin JJ JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):627-33. PubMed ID: 27281111 [TBL] [Abstract][Full Text] [Related]
23. Focus on gastroesophageal reflux (GER) and laryngopharyngeal reflux (LPR): new pragmatic insights in clinical practice. Gelardi M; Ciprandi G J Biol Regul Homeost Agents; 2018 Jan-Feb,; 32(1 Suppl. 2):41-47. PubMed ID: 29436209 [TBL] [Abstract][Full Text] [Related]
24. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS? Azzam RS Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291 [TBL] [Abstract][Full Text] [Related]
25. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study. MacFarlane B; Matthews A; Bergin J Int J Clin Pharm; 2015 Oct; 37(5):851-6. PubMed ID: 25972205 [TBL] [Abstract][Full Text] [Related]
26. Survey of primary care physicians' approach to gastroesophageal reflux disease in elderly patients. Wilcox CM; Heudebert G; Klapow J; Shewchuk R; Casebeer L J Gerontol A Biol Sci Med Sci; 2001 Aug; 56(8):M514-7. PubMed ID: 11487605 [TBL] [Abstract][Full Text] [Related]
27. Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy. Miyamoto M; Haruma K; Takeuchi K; Kuwabara M J Gastroenterol Hepatol; 2008 May; 23(5):746-51. PubMed ID: 18028348 [TBL] [Abstract][Full Text] [Related]
28. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine. Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849 [TBL] [Abstract][Full Text] [Related]
29. BRAZILIAN PHYSICIANS' PRACTICES ON THE MANAGEMENT OF SYMPTOMS SUGGESTING GASTROESOPHAGEAL REFLUX DISEASE: A MULTIDISCIPLINARY SURVEY. Chinzon D; Moraes-Filho JPP; Domingues G; Roveda F; LobÃo Neto AA; Zaterka S Arq Gastroenterol; 2020; 57(4):404-408. PubMed ID: 33331473 [TBL] [Abstract][Full Text] [Related]
30. Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherence. Solem C; Mody R; Stephens J; Macahilig C; Gao X J Am Pharm Assoc (2003); 2014; 54(2):144-53. PubMed ID: 24632930 [TBL] [Abstract][Full Text] [Related]
31. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358 [TBL] [Abstract][Full Text] [Related]
32. Treatment of gastroesophageal reflux disease. Pettit M Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949 [TBL] [Abstract][Full Text] [Related]
33. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors. Johnson DA; Levy BH Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445 [TBL] [Abstract][Full Text] [Related]
34. Medical treatments of GERD: the old and new. Vela MF Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363 [TBL] [Abstract][Full Text] [Related]
35. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282 [TBL] [Abstract][Full Text] [Related]
36. The pharmacological management of gastroesophageal reflux disease. Lowe RC; Wolfe MM Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198 [TBL] [Abstract][Full Text] [Related]
39. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel. Lødrup A; Reimer C; Bytzer P Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of treatment pattern and symptom control in patients with gastroesophageal reflux disease: multihospital questionnaire survey on the current situation in Korea. Seo SI; Bang CS; Kang HS; Choi MH; Shin WG; Jang HJ; Kim JB; Baik KH; Kae SH; Kim HY Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]